These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27632342)

  • 21. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus.
    Kalakota K; Liauw SL
    Urology; 2013 Jun; 81(6):1196-201. PubMed ID: 23540863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data.
    Karsh LI; Gross ET; Pieczonka CM; Aliotta PJ; Skomra CJ; Ponsky LE; Nieh PT; Han M; Hamstra DA; Shore ND
    Urology; 2018 May; 115():39-44. PubMed ID: 29174940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study.
    Dinh TT; Lee HJ; Macomber MW; Apisarnthanarax S; Zeng J; Laramore GE; Rengan R; Russell KJ; Chen JJ; Ellis WJ; Schade GR; Liao JJ
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):635-643. PubMed ID: 32035187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CT : Clinical results and quality of life.
    Schlenter M; Berneking V; Krenkel B; Mottaghy FM; Vögeli TA; Eble MJ; Pinkawa M
    Strahlenther Onkol; 2018 Jul; 194(7):638-645. PubMed ID: 29511777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How I Do It: Hydrogel spacer placement in men scheduled to undergo prostate radiotherapy.
    Montoya J; Gross E; Karsh L
    Can J Urol; 2018 Apr; 25(2):9288-9293. PubMed ID: 29680009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rectal morbidity after permanent interstitial brachytherapy for prostate cancer--impact of day 1 vs. day 30 computed tomography-based postimplant dosimetry.
    Pinkawa M; Piroth MD; Holy R; Klotz J; Nussen S; Borchers H; Heidenreich A; Eble MJ
    Brachytherapy; 2010; 9(1):1-7. PubMed ID: 19733126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of hydrogel spacer in men undergoing high-dose prostate cancer radiotherapy: results of a prospective phase 2 clinical trial.
    Chao M; Lim Joon D; Khoo V; Lawrentschuk N; Ho H; Spencer S; Chan Y; Tan A; Pham T; Sengupta S; McMillan K; Liu M; Koufogiannis G; Cham CW; Foroudi F; Bolton D
    World J Urol; 2019 Jun; 37(6):1111-1116. PubMed ID: 30251049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy.
    Hatiboglu G; Pinkawa M; Vallée JP; Hadaschik B; Hohenfellner M
    BJU Int; 2012 Dec; 110(11 Pt B):E647-52. PubMed ID: 22788857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Searching for optimal dose-volume constraints to reduce rectal toxicity after hypofractionated radiotherapy for prostate cancer.
    Faria S; Joshua B; Patrocinio H; Dal Pra A; Cury F; Velly AM; Souhami L
    Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):810-7. PubMed ID: 20980135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrogel spacers in prostate radiotherapy: a promising approach to decrease rectal toxicity.
    Padmanabhan R; Pinkawa M; Song DY
    Future Oncol; 2017 Dec; 13(29):2697-2708. PubMed ID: 29168659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer].
    Ung M; Bossi A; Abbassi L; Vautier J; Anthonipillai V; Chevé M; Blanchard P
    Cancer Radiother; 2021 May; 25(3):237-241. PubMed ID: 33419606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial.
    Chen RC; Zhang Y; Chen MH; McMahon E; Loffredo M; McPherson CP; Nguyen AU; Nguyen PL; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1690-5. PubMed ID: 22502770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.
    Prada PJ; Fernández J; Martinez AA; de la Rúa A; Gonzalez JM; Fernandez JM; Juan G
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):95-102. PubMed ID: 17707267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rectal dose constraints for intensity modulated radiation therapy of the prostate.
    Swanson GP; Stathakis S
    Am J Clin Oncol; 2011 Apr; 34(2):188-95. PubMed ID: 20622649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate Cancer.
    Boissier R; Udrescu C; Rebillard X; Terrier JE; Faix A; Chapet O; Azria D; Devonec M; Paparel P; Ruffion A
    Urology; 2017 Jan; 99():265-269. PubMed ID: 27725233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial.
    Hamstra DA; Mariados N; Sylvester J; Shah D; Gross E; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Daignault-Newton S; Fischer-Valuck BW; Chundury A; Gay HA; Bosch W; Michalski J
    Pract Radiat Oncol; 2018; 8(1):e7-e15. PubMed ID: 28951089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incremental changes verses a technological quantum leap: the additional value of intensity-modulated radiotherapy beyond image-guided radiotherapy for prostate irradiation.
    Ratnayake G; Martin J; Plank A; Wong W
    J Med Imaging Radiat Oncol; 2014 Aug; 58(4):503-10. PubMed ID: 25243269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SpaceOAR Hydrogel Spacer for Reducing Radiation Toxicity During Radiotherapy for Prostate Cancer. A Systematic Review.
    Armstrong N; Bahl A; Pinkawa M; Ryder S; Ahmadu C; Ross J; Bhattacharyya S; Woodward E; Battaglia S; Binns J; Payne H
    Urology; 2021 Oct; 156():e74-e85. PubMed ID: 34029607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early hematologic changes during prostate cancer radiotherapy predictive for late urinary and bowel toxicity.
    Pinkawa M; Ribbing C; Djukic V; Klotz J; Holy R; Eble MJ
    Strahlenther Onkol; 2015 Oct; 191(10):771-7. PubMed ID: 26009493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.